论文部分内容阅读
2年来 ,Ⅲ类抗心律失常药物治疗有了明显进步。用埋藏式心脏转复除颤器 (ＩＣＤ)的室性心律失常病人 ,Ⅲ类药的采用日增 ,以期减少ＩＣＤ放电次数。最近研究反映Ｓｏｔａｌｏｌ有减少ＩＣＤ病人的快速性心律失常之效。目前正在研究静脉注射胺碘酮用于急性处理不稳定性室性心律
2 years, Ⅲ anti-arrhythmic drug treatment has made significant progress. Patients with ventricular arrhythmias using an implanted cardioverter defibrillator (ICD) have an increasing use of class III drugs to reduce the number of ICD discharges. Recent studies have shown that Sotalol has the effect of reducing tachyarrhythmia in ICD patients. Amiodarone is currently being studied for the acute management of unstable ventricular arrhythmias